相关实验视频
Updated: May 24, 2025

06:47
Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
741
果仁果园 (Gardeniae Fructus) 衍生出天然的基于小分子的碳点,促进血小板的激活和聚合,以加速血液静止
Jiawen Zhang1, Yong Hou2, Xueshan Xu3
1Key Laboratory of Bioactive Substances and Resource Utilization of Chinese Herbal Medicine, Ministry of Education, Institute of Medicinal Plant Development, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100193, China.
Colloids and surfaces. B, Biointerfaces
|March 2, 2025
概括
研究人员从传统中医药中开发出基因化碳点 (Gen-CDs),以改善血液静止. 这些Gen-CD显示出通过促进血小板激活和聚合来治疗出血的巨大潜力.
科学领域:
- 生物材料科学 生物材料科学
- 传统中国医药 传统中国医药
- 血液静止研究 血液静止研究
背景情况:
- 对于组织损伤的有效血静仍然是一个挑战.
- 传统中国医学 (TCM) 使用碳化草药治疗出血,但机制尚不清楚.
- 研究TCM的小分子成分是了解它们有效性的关键.
研究的目的:
- 开发和特征基因化碳点 (Gen-CDs) 来自花果树的血液静止.
- 为了阐明基因-CDs的静血机制,从关键的TCM组件中衍生出来.
- 在各种动物模型中评估Gen-CDs的静血性能.
主要方法:
- 基因CDs是用修改的热水方法从基因合成的.
- 用小鼠肝损伤,尾巴截肢和大鼠血热出血模型来评估静血活性.
- 为了分析血小板激活和聚合,进行了体外和体内实验.
主要成果:
- 基因CDs已成功准备,具有增强的水溶性和生物可用性.
- 基因CD在外源性和内源性出血模型中表现出显著的静血活性.
- 实验证实,Gen-CDs有效地促进了血小板激活和聚合.
结论:
- 基因-CDs代表了一种有希望的新方法,用于有效和快速的血液静止.
- 这项研究提供了对碳化TCM草药的药理学基础和机制的见解.
- 基因CD为开发先进的静血剂提供了一个新的视角.
相关概念视频
Formation of the Platelet Plug
3.7K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
3.7K
Structure and Function of Platelets
943
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
943
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
454
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
454
Clot Retraction and Fibrinolysis
3.3K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
3.3K
Coagulation
4.1K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
4.1K

